Stereotaxis Robotic Technology Reduces Incidence of Silent Cerebral Embolism During Atrial Fibrillation Ablation in New Peer-Reviewed Publication

NEXT STORY
Checkpoint Therapeutics Announces Initiation of CONTERNO Phase 3 Trial of Cosibelimab Combined with Chemotherapy in Patients with First-Line Non-Squamous Non-Small Cell Lung Cancer
PREV STORY
Acrivon Therapeutics Announces its Scientific Advisory Board with Renowned Oncology Thought Leaders
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Junshi Biosciences and Coherus Announce Completion of Rolling BLA Submission to U.S. FDA for Toripalimab for the Treatment of Nasopharyngeal Carcinoma

author_avatar
NASDAQ Market News

VALNEVA : First sales of Flu Vaccines Produced on Valneva’s EB66(r) Cell-Line

First sales of Flu Vaccines Produced on Valneva's EB66 ® Cell-Line Valneva to begin receiving ...

author_avatar
NASDAQ Market News

First Patient Dosed in IPH5201 Phase I Clinical Trial in Advanced Solid Tumors

author_avatar
NASDAQ Market News